Richard A. Brown, Chairman and co-founder of Niadyne Pharma serves as Chief Executive Officer. Mr. Brown
has been in the investment business since 1972 and has been president of Eagle Ventures, a venture capital investment company, since 1986. He has been an investor in
and director of a number of science based public and private companies, has successfully raised money for several start up ventures and has been involved in the initial public offerings of a number of
technology based companies as an investor, director and investment banker. Most recently he was chairman of the board of Oxigene, Inc., a company he co-founded, that is engaged in the development
of therapeutic products based on the interrelationship of DNA repair and cell replication relating to cancer and immune disorders.
Elaine L. Jacobson Ph.D., Co-founder of Niadyne Pharma serves as Chief Operating Officer. Dr. Jacobson holds a Ph.D. degree in
biochemistry and is a Fellow of the American College of Nutrition. She also completed postdoctoral training in cell and molecular biology. She has been a University professor since 1977, directing a research team interested in the fundamental
mechanisms of cell growth control and cancer. Highly competitive federal grants and private funding have continuously funded her pioneering research on the functions of niacin and NAD in DNA repair. She has published more than 100 articles
based on this research in prestigious journals such as Science, Cancer Research, and The Journal of Biological Chemistry. Dr. Jacobson is currently Professor of Pharmacology and Toxicology at the
University of Arizona College of Pharmacy and a member of the Arizona Cancer Center. Dr. Jacobson has held leadership roles in numerous national
and international functions including that as an organizer of international meetings on NAD functions in DNA repair, a committee member for the National Legislative Committee of the American Association for Cancer Research and a member
of one of the National Institutes of Health Scientific Review Committees. Dr. Jacobson is an expert in understanding how human health can be maintained through direct nutritional support.
Myron K. Jacobson Ph.D., Chief Scientific Officer and co-founder of Niadyne Pharma, holds a Ph.D. degree in biochemistry and completed postdoctoral training in molecular
biology. He has been a faculty member since 1974 and from 1992 until 1998 was Chairman of the Division of Medicinal Chemistry and Pharmaceutics at the University of Kentucky. He is currently Professor of Medicinal Chemistry at the
University of Arizona College of Pharmacy and a member of the Arizona Cancer Center. He has published more than 100 scientific papers in the area
of DNA repair and protein modification in scientific journals that include Science, Nature, and the Proceedings of the National Academy of Sciences. His research has been funded continuously by grants from the National
Institutes of Health since 1977. He has served as a member of numerous national review panels, as a consultant to several companies. Dr. Jacobson
is a leading expert in understanding the mechanisms of DNA and protein damage, and DNA repair.
